Health TrialsbyHealthPanel

Artificial Intelligence for Highly Myopic Cataract

ConditionsCataractHigh MyopiaMyopiaAutomatic JudgementRisk ReductionDiagnoses Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorShanghai High Myopia Study Group

About this trial

This study aims to establish a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highly myopic cataract, so as to improve the accuracy of the prediction of postoperative diopter in highly myopic cataract patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Prospective Cohort Study

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • newly-invented AI model

    Device

    Apply newly-invented AI models to assist in determining surgical plans and outcome prediction.

Treatment groups

500,000 Participants
are divided into 4 treatment groups
Group A: Highly myopic cataract patients without fundus defects1 intervention
Group B: Highly myopic cataract patients with fundus defects1 intervention
Group C: Highly myopic cataract patients with lens grading of NC2-31 intervention
Group D: Highly myopic cataract patients with lens grading of NC4-51 intervention

Trial outcomes

Primary outcomes

1

a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highly myopic cataract

Time frame
10 YEARS
2

a multi-center artificial intelligence model for the cataract grading and its clinical application in highly myopic cataract

Time frame
8 years

Secondary outcomes

1

a multi-center artificial intelligence model for the risk prediction of perioperative complications and its clinical application in highly myopic cataract

Time frame
10 years
2

a multi-center artificial intelligence model for the surgical outcome prediction and its clinical application in highly myopic cataract

Time frame
10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Shanghai High Myopia Study Group

Lead sponsor

Eye and ENT Hospital of Fudan University

Collaborator

Source ClinicalTrials.gov
Apply now